Correlation Engine 2.0
Clear Search sequence regions

  • africa (1)
  • antibodies (3)
  • disease outbreaks (1)
  • ebolavirus (6)
  • fever (2)
  • humans (1)
  • outbreaks (1)
  • peptides (1)
  • Sizes of these terms reflect their relevance to your search.

    Ebola virus (EBOV) is one of the most deadliest agents already known, causing periodic epidemic of a severe hemorrhagic fever disease in Africa. Although two monoclonal antibody (mAb) drugs have recently received approval in the USA, additional therapeutics are still needed to combat potential outbreaks of resistance variants and other closely related ebola viruses. In this chapter, we describe the current understanding of the EBOV entry process and summarize the approaches, strategies, and advances in discovery and development of EBOV entry inhibitors, including therapeutic antibodies, peptides, small molecules, natural products, and other chemical structures. © 2022. Springer Nature Singapore Pte Ltd.


    Ruikun Du, Qinghua Cui, Michael Caffrey, Lijun Rong. Ebola Virus Entry Inhibitors. Advances in experimental medicine and biology. 2022;1366:155-170

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 35412140

    View Full Text